Paper · 42976199
Temporal Trends in the Prevalence of Frailty in England From 2002 to 2022, With Forecasts to 2040: Longitudinal Secondary Analysis of a National Cohort Study.
Tang D and 6 others. JMIR Aging, 2026.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Temporal Trends in the Prevalence of Frailty in England From 2002 to 2022, With Forecasts to 2040: Longitudinal Secondary Analysis of a National Cohort Study. Papers, record 42976199. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42976199
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Temporal Trends in the Prevalence of Frailty in England From 2002 to 2022, With Forecasts to 2040: Longitudinal Secondary Analysis of a National Cohort Study.
- Journal
- JMIR Aging
- Year
- 2026
- Publication types
- Journal Article
- Revised in PubMed
- 2026-11-05
Source PubMed
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Frailty | Major topic |
| Frail Elderly | Major topic |
| Humans | |
| England | |
| Female | |
| Prevalence | |
| Male | |
| Longitudinal Studies | |
| Middle Aged | |
| Aged | |
| Forecasting | |
| Aged, 80 and over | |
| Cohort Studies | |
| Independent Living |
Source PubMed
Grants0
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
None in this release.
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References38
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 37,489,714 | Trends in Frailty Prevalence Among Older Adults in Korea: A Nationwide Study From 2008 to 2020. | J Korean Med Sci | 2023 | https://conductscience.org/library/papers/37489714 | PubMed |
| 2 | 23,395,245 | Frailty in elderly people. | Lancet | 2013 | https://conductscience.org/library/papers/23395245 | PubMed |
| 3 | 25,313,241 | Prevalence of frailty and disability: findings from the English Longitudinal Study of Ageing. | Age Ageing | 2015 | https://conductscience.org/library/papers/25313241 | PubMed |
| 4 | 37,140,052 | Frailty transitions and prevalence in an ageing population: longitudinal analysis of primary care data from an open cohort of adults aged 50 and over in England, 2006-2017. | Age Ageing | 2023 | https://conductscience.org/library/papers/37140052 | PubMed |
| 5 | 39,983,748 | Changing life expectancy in European countries 1990-2021: a subanalysis of causes and risk factors from the Global Burden of Disease Study 2021. | Lancet Public Health | 2025 | https://conductscience.org/library/papers/39983748 | PubMed |
| 6 | 31,258,113 | Increasing healthy life expectancy equitably in England by 5 years by 2035: could it be achieved? | Lancet | 2019 | https://conductscience.org/library/papers/31258113 | PubMed |
| 7 | 36,423,656 | Nowcasting and forecasting the care needs of the older population in China: analysis of data from the China Health and Retirement Longitudinal Study (CHARLS). | Lancet Public Health | 2022 | https://conductscience.org/library/papers/36423656 | PubMed |
| 8 | 39,140,371 | Secular trends in frailty among community-dwelling 75-95-year-old cohorts over three decades in Helsinki, Finland. | Age Ageing | 2024 | https://conductscience.org/library/papers/39140371 | PubMed |
| 9 | 39,441,508 | Identifying modifiable factors and their joint effect on frailty: a large population-based prospective cohort study. | Geroscience | 2025 | https://conductscience.org/library/papers/39441508 | PubMed |
| 10 | 35,844,770 | Contribution of life course circumstances to the acceleration of phenotypic and functional aging: A retrospective study. | EClinicalMedicine | 2022 | https://conductscience.org/library/papers/35844770 | PubMed |
1 to 10 of 38
See all 38 referencesCited by0
The papers in our copy of PubMed whose reference list names this one, newest first.
None in this release.
Genes0
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
None in this release.
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42976199
GET https://conductscience.org/api/papers/v1/42976199/references?page=2